Key result
From 1990 to 2019, the global crude mortality rate for hypertensive heart disease rose from 12.2 to 14.9 per 100,000, whereas the age-adjusted mortality rate declined from 19.3 to 15.1 per 100,000.
Why the study?
The study was conducted to examine global hypertensive heart disease trends from 1990 to 2019.
Observational
Yes
Absolute Event Rate: 15.1% vs 19.3%
While age-adjusted mortality rates for hypertensive heart disease have declined globally from 1990 to 2019, crude mortality and years lived with disability have increased, highlighting a growing chronic burden.
Indicates expanding HHD burden despite age-adjusted gains; leaves open targeted prevention strategies in aging populations.
This study aimed to examine global hypertensive heart disease (HHD) trends (1990–2019). Methods: We extracted data from the Global Burden of Disease (GBD) 2019 Study, encompassing 204 countries and territories. We analyzed the age-adjusted mortality rates (AAMRs), crude mortality, prevalence, years lived with disability (YLD), years of life lost (YLL), and disability-adjusted life years (DALY). Joinpoint Regression Analysis was used to calculate the Annual Percentage Change (APC), with p < 0.05 indicating statistical significance. Results were stratified by region, Socio-Demographic Index (SDI), and gender. Results: Globally, the crude mortality rate for HHD rose from 12.2 (95% UI 9.9–13.6) to 14.9 (95% UI 16.5–11.1) deaths/100,000 population (1990–2019), whereas the AAMR declined from 19.3 (95% UI 5.8–21.6) to 15.1 (95% UI 11.1–16.7). A Joinpoint Analysis revealed significant APC shifts: a decrease of −1.53% (p < 0.05) from 1990 to 2006, an increase of +0.60% (p < 0.05) from 2006 to 2015, and a subsequent decrease of −1.28% (p < 0.05) from 2006 to 2019. Eastern Europe showed the highest annual rate of change in AAMR at 0.9 (95% UI: −0.1 to 1.2), whereas the high-income Asia Pacific region experienced the largest decline at −0.66 (95% UI −0.27–−0.72). Central Asian males had an AAMR of 31.1 (95% UI 35.3–22.9) in 2019, and Sub-Saharan African females reached 38.5 (95% UI 48.4–26.3). YLL trended downward in both sexes (APC: −1.94, p < 0.05 in males; −1.81, p < 0.05 in females), yet YLD rose steadily in recent years, underscoring a growing chronic burden. The AAMR was highest in 2019 among Sub-Saharan African females, which is a particularly important area. Conclusions: Targeted strategies are essential to mitigate the escalating HHD burden.
No takes yet. Share an insight, caveat, or question.
Khalid et al. (2025) conducted an observational in Hypertensive heart disease. Time period (2019) vs. Time period (1990) was evaluated on Age-adjusted mortality rate (AAMR) per 100,000 population. From 1990 to 2019, the global crude mortality rate for hypertensive heart disease rose from 12.2 to 14.9 per 100,000, whereas the age-adjusted mortality rate declined from 19.3 to 15.1 per 100,000.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: